Stifel lowered the firm’s price target on Paycor HCM to $19 from $22 and keeps a Buy rating on the shares. Paycor’s Q4 results beat expectations across the board driven by upside from strong cross-selling and new employee growth and it appears management’s FY25 guidance has sufficient conservatism for the company to continue to beat in coming quarters, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PYCR:
- Paycor HCM price target lowered to $20 from $33 at Truist
- PYCR Earnings this Week: How Will it Perform?
- Paycor HCM announces the release of Paycor Compensation Management
- New Compensation Management Solution Drives Pay Transparency, Retention and Engagement
- Paycor HCM price target lowered to $15 from $19 at Mizuho